These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16158916)

  • 1. WP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute myeloid leukemia (AML).
    Faderl S; Ferrajoli A; Harris D; Van Q; Priebe W; Estrov Z
    Anticancer Res; 2005; 25(3B):1841-50. PubMed ID: 16158916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells.
    Ferrajoli A; Faderl S; Van Q; Koch P; Harris D; Liu Z; Hazan-Halevy I; Wang Y; Kantarjian HM; Priebe W; Estrov Z
    Cancer Res; 2007 Dec; 67(23):11291-9. PubMed ID: 18056455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia.
    Faderl S; Harris D; Van Q; Kantarjian HM; Talpaz M; Estrov Z
    Blood; 2003 Jul; 102(2):630-7. PubMed ID: 12663443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive activation of STAT transcription factors in acute myelogenous leukemia.
    Spiekermann K; Biethahn S; Wilde S; Hiddemann W; Alves F
    Eur J Haematol; 2001 Aug; 67(2):63-71. PubMed ID: 11722592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells.
    Estrov Z; Manna SK; Harris D; Van Q; Estey EH; Kantarjian HM; Talpaz M; Aggarwal BB
    Blood; 1999 Oct; 94(8):2844-53. PubMed ID: 10515888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kit inhibitor APcK110 induces apoptosis and inhibits proliferation of acute myeloid leukemia cells.
    Faderl S; Pal A; Bornmann W; Albitar M; Maxwell D; Van Q; Peng Z; Harris D; Liu Z; Hazan-Halevy I; Kantarjian HM; Estrov Z
    Cancer Res; 2009 May; 69(9):3910-7. PubMed ID: 19383925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.
    Hayakawa F; Towatari M; Iida H; Wakao H; Kiyoi H; Naoe T; Saito H
    Br J Haematol; 1998 Jun; 101(3):521-8. PubMed ID: 9633897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells.
    Estrov Z; Shishodia S; Faderl S; Harris D; Van Q; Kantarjian HM; Talpaz M; Aggarwal BB
    Blood; 2003 Aug; 102(3):987-95. PubMed ID: 12689943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In BCR-ABL-positive cells, STAT-5 tyrosine-phosphorylation integrates signals induced by imatinib mesylate and Ara-C.
    Kindler T; Breitenbuecher F; Kasper S; Stevens T; Carius B; Gschaidmeier H; Huber C; Fischer T
    Leukemia; 2003 Jun; 17(6):999-1009. PubMed ID: 12764361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of IL-6-induced STAT3 tyrosine phosphorylation by TGF-beta1 is mediated by caspase-dependent and -independent processes.
    Wierenga AT; Schuringa JJ; Eggen BJ; Kruijer W; Vellenga E
    Leukemia; 2002 Apr; 16(4):675-82. PubMed ID: 11960349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3.
    Bali P; George P; Cohen P; Tao J; Guo F; Sigua C; Vishvanath A; Scuto A; Annavarapu S; Fiskus W; Moscinski L; Atadja P; Bhalla K
    Clin Cancer Res; 2004 Aug; 10(15):4991-7. PubMed ID: 15297399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.
    Faderl S; Estrov Z; Kantarjian HM; Harris D; Van Q; Fokt I; Przewloka T; Godlewski C; Woynarowski JM; Priebe W
    Anticancer Res; 2001; 21(6A):3777-84. PubMed ID: 11911247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atiprimod blocks phosphorylation of JAK-STAT and inhibits proliferation of acute myeloid leukemia (AML) cells.
    Faderl S; Ferrajoli A; Harris D; Van Q; Kantarjian HM; Estrov Z
    Leuk Res; 2007 Jan; 31(1):91-5. PubMed ID: 16828865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts.
    Xia Z; Baer MR; Block AW; Baumann H; Wetzler M
    Cancer Res; 1998 Jul; 58(14):3173-80. PubMed ID: 9679986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes.
    Bright JJ; Sriram S
    J Immunol; 1998 Aug; 161(4):1772-7. PubMed ID: 9712043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells.
    Tong H; Ren Y; Zhang F; Jin J
    Eur J Haematol; 2008 Oct; 81(4):259-66. PubMed ID: 18616510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
    Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
    J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of differentiation by IL-6-type cytokines is impaired in myeloid leukaemia cells unable to activate Stat5a.
    Piekorz RP; Hocke GM
    Cytokine; 1997 Sep; 9(9):639-49. PubMed ID: 9325012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
    Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
    Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma.
    Uddin S; Hussain AR; Manogaran PS; Al-Hussein K; Platanias LC; Gutierrez MI; Bhatia KG
    Oncogene; 2005 Oct; 24(47):7022-30. PubMed ID: 16044161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.